The Roswell incident of 1947 was a cover-up! The US government approved the release of documents following a FOIA request that the debris found in Roswell, NM, in 1947 was not from the Project Mogul nuclear test surveillance balloon as previously claimed, but it was indeed an alien space ship that had landed. The famous alien autopsy footage that Ray Santilli had released in 1995 (seen here:The Alien Autopsy) turned out to not be a complete hoax. When contacted, Ray Santilli insists on his 2006 claim that the film was not authentic but rather a staged reconstruction of footage he had viewed in 1992.
The new information released confirms that an alien autopsy had indeed taken place. The research on the captured alien was extensive pre- and post-mortem. This new information has sparked the interest of the Gillette Lab in the University of New Mexico. The lab has long been interested in studying how cell communication within the bone marrow microenvironment serves to regulate healthy and malignant cells.
Interestingly, a routine immunocytochemistry for stem cell markers on the alien produced a strange finding: A protein very similar to the human oct4 primordial germ cell (pgc) marker was expressed in what appeared to be a small subset of stem cells, but in stem cells from every tissue examined! Meaning in addition to the germ cells of this alien's gonads, each tissue’s stem cell niche housed these same pgc-like stem cells—muscle, gut, brain, bone marrow… all of them!
This finding has now spurred the controversial question of whether this alien species could provide the evidence that the germ cell is potentially pluripotent and potentially the true immortal cell. Now, that would be an alien worth communicating with, a species that could convince the world’s leaders that space exploration is worth funding as it may potentially harbor new cell-based therapies for regenerative medicine.
Excited by the importance of this alien species, now named “Rosalien,” the Gillette lab was awarded a grant from NASA and the emergency international science fund. You are the new postdoctoral fellow just hired by Dr. Gillette's laboratory right in the middle of this discovery. What are you going to do to demonstrate the therapeutic potential of these cells?
1 answer
To start, I would perform molecular profiling to identify the genes and proteins expressed by these pgc-like stem cells. This information would help us understand their similarities and differences with human stem cells. Additionally, I would investigate the signaling pathways and mechanisms that regulate the behavior of these cells.
Next, I would explore the potential of these pgc-like stem cells for regenerative medicine by conducting in vitro experiments. I would culture these cells and examine their ability to differentiate into specialized cell types found in different tissues. For example, I would induce their differentiation into muscle, gut, brain, or bone marrow cells, among others. These differentiated cells could then be analyzed for their functionality and compared to their natural counterparts.
Simultaneously, I would work on developing animal models to further study the therapeutic potential of these stem cells. By transplanting the Rosalien pgc-like stem cells into animal models with specific diseases or injuries, we could assess their ability to regenerate damaged tissues or restore functionality.
I would collaborate with other researchers and institutes working in the field of regenerative medicine to exchange knowledge and expertise, and explore potential partnerships for further studies.
To communicate the therapeutic potential of these cells, I would present our findings at scientific conferences, publish research papers in reputable journals, and actively engage with the scientific community through discussions and collaborations. By highlighting the unique properties of these pgc-like stem cells, we could generate interest and gather support, ultimately aiming to secure additional funding for further research.
Moreover, I would also initiate discussions with regulatory authorities and ethical committees to ensure the responsible and ethical use of these cells in future therapeutic applications. It would be crucial to address any potential concerns or ethical implications associated with utilizing stem cells from an extraterrestrial species.
In summary, my approach would involve comprehensive characterization, in vitro experiments, animal studies, collaboration, research dissemination, and ethical considerations to demonstrate the therapeutic potential of the Rosalien pgc-like stem cells. By providing compelling evidence of their regenerative capabilities, we could pave the way for future advancements in cell-based therapies for regenerative medicine.